Trial Profile
A PMS study to investigate safety and efficacy of Abatacept in Japanese patients with Rheumatoid Arthritis.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 05 Dec 2015
Price :
$35
*
At a glance
- Drugs Abatacept (Primary)
- Indications Rheumatoid arthritis
- Focus Adverse reactions; Therapeutic Use
- 05 Dec 2015 New trial record